English
简体中文
Total: £ 56.28
Published Date: 2025-07-09 | Pages: 79 | Tables: 81 | Pharma & Healthcare
The global market for Cobamamide Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cobamamide is mainly used for megaloblastic anemia, malnutrition anemia, pregnancy anemia, polyneuritis, radiculopathy, trigeminal neuralgia, sciatica, nerve palsy, it can also be used for nutritional disorders, radiation, and drug-induced leukopenia.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cobamamide Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cobamamide Drugs.
The Cobamamide Drugs market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cobamamide Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cobamamide Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Haerbin Medisan
North China Pharmaceutical Group
Chongqing Yaoyou Pharmaceutical
Sinopharm Group Rongsheng Pharmaceutical
Hainan Star Pharmaceutical
Hebei Zhitong Biopharmaceutical
Jiangsu Jiuxu Pharmaceutical
Jiuquan Dadeli pharmaceutical
Segment by Type
Injection
Tablets
Segment by Application
Hospital
Drug Store
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cobamamide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cobamamide Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Cobamamide Drugs Market Overview
1.1 Product Definition
1.2 Cobamamide Drugs by Type
1.2.1 Global Cobamamide Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection
1.2.3 Tablets
1.3 Cobamamide Drugs by Application
1.3.1 Global Cobamamide Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Global Cobamamide Drugs Market Size Estimates and Forecasts
1.4.1 Global Cobamamide Drugs Revenue 2020-2031
1.4.2 Global Cobamamide Drugs Sales 2020-2031
1.4.3 Global Cobamamide Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cobamamide Drugs Market Competition by Manufacturers
2.1 Global Cobamamide Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cobamamide Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cobamamide Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cobamamide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cobamamide Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cobamamide Drugs, Product Type & Application
2.7 Global Key Manufacturers of Cobamamide Drugs, Date of Enter into This Industry
2.8 Global Cobamamide Drugs Market Competitive Situation and Trends
2.8.1 Global Cobamamide Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cobamamide Drugs Players Market Share by Revenue
2.8.3 Global Cobamamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cobamamide Drugs Market Scenario by Region
3.1 Global Cobamamide Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cobamamide Drugs Sales by Region: 2020-2031
3.2.1 Global Cobamamide Drugs Sales by Region: 2020-2025
3.2.2 Global Cobamamide Drugs Sales by Region: 2026-2031
3.3 Global Cobamamide Drugs Revenue by Region: 2020-2031
3.3.1 Global Cobamamide Drugs Revenue by Region: 2020-2025
3.3.2 Global Cobamamide Drugs Revenue by Region: 2026-2031
3.4 North America Cobamamide Drugs Market Facts & Figures by Country
3.4.1 North America Cobamamide Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cobamamide Drugs Sales by Country (2020-2031)
3.4.3 North America Cobamamide Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cobamamide Drugs Market Facts & Figures by Country
3.5.1 Europe Cobamamide Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cobamamide Drugs Sales by Country (2020-2031)
3.5.3 Europe Cobamamide Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cobamamide Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Cobamamide Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cobamamide Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Cobamamide Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cobamamide Drugs Market Facts & Figures by Country
3.7.1 Latin America Cobamamide Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cobamamide Drugs Sales by Country (2020-2031)
3.7.3 Latin America Cobamamide Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cobamamide Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Cobamamide Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cobamamide Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cobamamide Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cobamamide Drugs Sales by Type (2020-2031)
4.1.1 Global Cobamamide Drugs Sales by Type (2020-2025)
4.1.2 Global Cobamamide Drugs Sales by Type (2026-2031)
4.1.3 Global Cobamamide Drugs Sales Market Share by Type (2020-2031)
4.2 Global Cobamamide Drugs Revenue by Type (2020-2031)
4.2.1 Global Cobamamide Drugs Revenue by Type (2020-2025)
4.2.2 Global Cobamamide Drugs Revenue by Type (2026-2031)
4.2.3 Global Cobamamide Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Cobamamide Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cobamamide Drugs Sales by Application (2020-2031)
5.1.1 Global Cobamamide Drugs Sales by Application (2020-2025)
5.1.2 Global Cobamamide Drugs Sales by Application (2026-2031)
5.1.3 Global Cobamamide Drugs Sales Market Share by Application (2020-2031)
5.2 Global Cobamamide Drugs Revenue by Application (2020-2031)
5.2.1 Global Cobamamide Drugs Revenue by Application (2020-2025)
5.2.2 Global Cobamamide Drugs Revenue by Application (2026-2031)
5.2.3 Global Cobamamide Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Cobamamide Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Haerbin Medisan
6.1.1 Haerbin Medisan Company Information
6.1.2 Haerbin Medisan Description and Business Overview
6.1.3 Haerbin Medisan Cobamamide Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Haerbin Medisan Cobamamide Drugs Product Portfolio
6.1.5 Haerbin Medisan Recent Developments/Updates
6.2 North China Pharmaceutical Group
6.2.1 North China Pharmaceutical Group Company Information
6.2.2 North China Pharmaceutical Group Description and Business Overview
6.2.3 North China Pharmaceutical Group Cobamamide Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 North China Pharmaceutical Group Cobamamide Drugs Product Portfolio
6.2.5 North China Pharmaceutical Group Recent Developments/Updates
6.3 Chongqing Yaoyou Pharmaceutical
6.3.1 Chongqing Yaoyou Pharmaceutical Company Information
6.3.2 Chongqing Yaoyou Pharmaceutical Description and Business Overview
6.3.3 Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Product Portfolio
6.3.5 Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
6.4 Sinopharm Group Rongsheng Pharmaceutical
6.4.1 Sinopharm Group Rongsheng Pharmaceutical Company Information
6.4.2 Sinopharm Group Rongsheng Pharmaceutical Description and Business Overview
6.4.3 Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Product Portfolio
6.4.5 Sinopharm Group Rongsheng Pharmaceutical Recent Developments/Updates
6.5 Hainan Star Pharmaceutical
6.5.1 Hainan Star Pharmaceutical Company Information
6.5.2 Hainan Star Pharmaceutical Description and Business Overview
6.5.3 Hainan Star Pharmaceutical Cobamamide Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hainan Star Pharmaceutical Cobamamide Drugs Product Portfolio
6.5.5 Hainan Star Pharmaceutical Recent Developments/Updates
6.6 Hebei Zhitong Biopharmaceutical
6.6.1 Hebei Zhitong Biopharmaceutical Company Information
6.6.2 Hebei Zhitong Biopharmaceutical Description and Business Overview
6.6.3 Hebei Zhitong Biopharmaceutical Cobamamide Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hebei Zhitong Biopharmaceutical Cobamamide Drugs Product Portfolio
6.6.5 Hebei Zhitong Biopharmaceutical Recent Developments/Updates
6.7 Jiangsu Jiuxu Pharmaceutical
6.7.1 Jiangsu Jiuxu Pharmaceutical Company Information
6.7.2 Jiangsu Jiuxu Pharmaceutical Description and Business Overview
6.7.3 Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Product Portfolio
6.7.5 Jiangsu Jiuxu Pharmaceutical Recent Developments/Updates
6.8 Jiuquan Dadeli pharmaceutical
6.8.1 Jiuquan Dadeli pharmaceutical Company Information
6.8.2 Jiuquan Dadeli pharmaceutical Description and Business Overview
6.8.3 Jiuquan Dadeli pharmaceutical Cobamamide Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Jiuquan Dadeli pharmaceutical Cobamamide Drugs Product Portfolio
6.8.5 Jiuquan Dadeli pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cobamamide Drugs Industry Chain Analysis
7.2 Cobamamide Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cobamamide Drugs Production Mode & Process Analysis
7.4 Cobamamide Drugs Sales and Marketing
7.4.1 Cobamamide Drugs Sales Channels
7.4.2 Cobamamide Drugs Distributors
7.5 Cobamamide Drugs Customer Analysis
8 Cobamamide Drugs Market Dynamics
8.1 Cobamamide Drugs Industry Trends
8.2 Cobamamide Drugs Market Drivers
8.3 Cobamamide Drugs Market Challenges
8.4 Cobamamide Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Cobamamide Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Cobamamide Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Cobamamide Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Cobamamide Drugs Sales (Kg) of Key Manufacturers (2020-2025)
Table 5. Global Cobamamide Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Cobamamide Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Cobamamide Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Cobamamide Drugs Average Price (US$/g) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Cobamamide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cobamamide Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cobamamide Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Cobamamide Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cobamamide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cobamamide Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cobamamide Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Cobamamide Drugs Sales by Region (2020-2025) & (Kg)
Table 18. Global Cobamamide Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Cobamamide Drugs Sales by Region (2026-2031) & (Kg)
Table 20. Global Cobamamide Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Cobamamide Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Cobamamide Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Cobamamide Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Cobamamide Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Cobamamide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Cobamamide Drugs Sales by Country (2020-2025) & (Kg)
Table 27. North America Cobamamide Drugs Sales by Country (2026-2031) & (Kg)
Table 28. North America Cobamamide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Cobamamide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Cobamamide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Cobamamide Drugs Sales by Country (2020-2025) & (Kg)
Table 32. Europe Cobamamide Drugs Sales by Country (2026-2031) & (Kg)
Table 33. Europe Cobamamide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Cobamamide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Cobamamide Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Cobamamide Drugs Sales by Region (2020-2025) & (Kg)
Table 37. Asia Pacific Cobamamide Drugs Sales by Region (2026-2031) & (Kg)
Table 38. Asia Pacific Cobamamide Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Cobamamide Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cobamamide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Cobamamide Drugs Sales by Country (2020-2025) & (Kg)
Table 42. Latin America Cobamamide Drugs Sales by Country (2026-2031) & (Kg)
Table 43. Latin America Cobamamide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cobamamide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Cobamamide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Cobamamide Drugs Sales by Country (2020-2025) & (Kg)
Table 47. Middle East and Africa Cobamamide Drugs Sales by Country (2026-2031) & (Kg)
Table 48. Middle East and Africa Cobamamide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Cobamamide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Cobamamide Drugs Sales (Kg) by Type (2020-2025)
Table 51. Global Cobamamide Drugs Sales (Kg) by Type (2026-2031)
Table 52. Global Cobamamide Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Cobamamide Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Cobamamide Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Cobamamide Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Cobamamide Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Cobamamide Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Cobamamide Drugs Price (US$/g) by Type (2020-2025)
Table 59. Global Cobamamide Drugs Price (US$/g) by Type (2026-2031)
Table 60. Global Cobamamide Drugs Sales (Kg) by Application (2020-2025)
Table 61. Global Cobamamide Drugs Sales (Kg) by Application (2026-2031)
Table 62. Global Cobamamide Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Cobamamide Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Cobamamide Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Cobamamide Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Cobamamide Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Cobamamide Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Cobamamide Drugs Price (US$/g) by Application (2020-2025)
Table 69. Global Cobamamide Drugs Price (US$/g) by Application (2026-2031)
Table 70. Haerbin Medisan Company Information
Table 71. Haerbin Medisan Description and Business Overview
Table 72. Haerbin Medisan Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 73. Haerbin Medisan Cobamamide Drugs Product
Table 74. Haerbin Medisan Recent Developments/Updates
Table 75. North China Pharmaceutical Group Company Information
Table 76. North China Pharmaceutical Group Description and Business Overview
Table 77. North China Pharmaceutical Group Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 78. North China Pharmaceutical Group Cobamamide Drugs Product
Table 79. North China Pharmaceutical Group Recent Developments/Updates
Table 80. Chongqing Yaoyou Pharmaceutical Company Information
Table 81. Chongqing Yaoyou Pharmaceutical Description and Business Overview
Table 82. Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 83. Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Product
Table 84. Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
Table 85. Sinopharm Group Rongsheng Pharmaceutical Company Information
Table 86. Sinopharm Group Rongsheng Pharmaceutical Description and Business Overview
Table 87. Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 88. Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Product
Table 89. Sinopharm Group Rongsheng Pharmaceutical Recent Developments/Updates
Table 90. Hainan Star Pharmaceutical Company Information
Table 91. Hainan Star Pharmaceutical Description and Business Overview
Table 92. Hainan Star Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 93. Hainan Star Pharmaceutical Cobamamide Drugs Product
Table 94. Hainan Star Pharmaceutical Recent Developments/Updates
Table 95. Hebei Zhitong Biopharmaceutical Company Information
Table 96. Hebei Zhitong Biopharmaceutical Description and Business Overview
Table 97. Hebei Zhitong Biopharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 98. Hebei Zhitong Biopharmaceutical Cobamamide Drugs Product
Table 99. Hebei Zhitong Biopharmaceutical Recent Developments/Updates
Table 100. Jiangsu Jiuxu Pharmaceutical Company Information
Table 101. Jiangsu Jiuxu Pharmaceutical Description and Business Overview
Table 102. Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 103. Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Product
Table 104. Jiangsu Jiuxu Pharmaceutical Recent Developments/Updates
Table 105. Jiuquan Dadeli pharmaceutical Company Information
Table 106. Jiuquan Dadeli pharmaceutical Description and Business Overview
Table 107. Jiuquan Dadeli pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 108. Jiuquan Dadeli pharmaceutical Cobamamide Drugs Product
Table 109. Jiuquan Dadeli pharmaceutical Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Cobamamide Drugs Distributors List
Table 113. Cobamamide Drugs Customers List
Table 114. Cobamamide Drugs Market Trends
Table 115. Cobamamide Drugs Market Drivers
Table 116. Cobamamide Drugs Market Challenges
Table 117. Cobamamide Drugs Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cobamamide Drugs
Figure 2. Global Cobamamide Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cobamamide Drugs Market Share by Type: 2024 & 2031
Figure 4. Injection Product Picture
Figure 5. Tablets Product Picture
Figure 6. Global Cobamamide Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Cobamamide Drugs Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Other
Figure 11. Global Cobamamide Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Cobamamide Drugs Market Size (2020-2031) & (US$ Million)
Figure 13. Global Cobamamide Drugs Sales (2020-2031) & (Kg)
Figure 14. Global Cobamamide Drugs Average Price (US$/g) & (2020-2031)
Figure 15. Cobamamide Drugs Report Years Considered
Figure 16. Cobamamide Drugs Sales Share by Manufacturers in 2024
Figure 17. Global Cobamamide Drugs Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Cobamamide Drugs Players: Market Share by Revenue in Cobamamide Drugs in 2024
Figure 19. Cobamamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Cobamamide Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Cobamamide Drugs Sales Market Share by Country (2020-2031)
Figure 22. North America Cobamamide Drugs Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Cobamamide Drugs Sales Market Share by Country (2020-2031)
Figure 26. Europe Cobamamide Drugs Revenue Market Share by Country (2020-2031)
Figure 27. Germany Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Cobamamide Drugs Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Cobamamide Drugs Revenue Market Share by Region (2020-2031)
Figure 34. China Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Cobamamide Drugs Sales Market Share by Country (2020-2031)
Figure 45. Latin America Cobamamide Drugs Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Cobamamide Drugs Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Cobamamide Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Cobamamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Cobamamide Drugs by Type (2020-2031)
Figure 55. Global Revenue Market Share of Cobamamide Drugs by Type (2020-2031)
Figure 56. Global Cobamamide Drugs Price (US$/g) by Type (2020-2031)
Figure 57. Global Sales Market Share of Cobamamide Drugs by Application (2020-2031)
Figure 58. Global Revenue Market Share of Cobamamide Drugs by Application (2020-2031)
Figure 59. Global Cobamamide Drugs Price (US$/g) by Application (2020-2031)
Figure 60. Cobamamide Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
